<DOC>
	<DOCNO>NCT02147938</DOCNO>
	<brief_summary>Assessment real situation conversion condition , efficacy safety treatment tacrolimus renal transplant patient convert tacrolimus twice per day form ( Prograf® ) tacrolimus per day form ( Advagraf® ) follow-up one year . Analysis two group patient : patient convert Prograf® Advagraf® early ( first 6 month post-transplantation ) late ( 6 12 month post-transplantation ) .</brief_summary>
	<brief_title>A Study Renal Transplant Patients Converted From Twice Per Day Form Tacrolimus ( Prograf® ) Once Per Day Form ( Advagraf® )</brief_title>
	<detailed_description />
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Renal transplant patient le one year Patient conversion Prograf® Advagraf® decide doctor Patient participate interventional clinical trial time inclusion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>France</keyword>
	<keyword>Tacrolimus</keyword>
	<keyword>Prograf</keyword>
	<keyword>Observational</keyword>
	<keyword>Advagraf</keyword>
</DOC>